Exela Technologies Reports Third Quarter 2017 Results
Nov 09, 2017 21:10 pm UTC| Business
Third Quarter Revenue of $358.2 Million, up 12.2% Year-over-Year on a Pro Forma Basis Third Quarter Further Adjusted EBITDA of $88.0 Million Affirms 2017 Financial Outlook and Tightens the Revenue Range to $1,450...
Immunomedics Announces First Quarter Fiscal 2018 Results and Provides Corporate Update
Nov 09, 2017 21:10 pm UTC| Business
Announces Appointments of Michael Pehl as President and Chief Executive Officer and Brendan Delaney as Chief Commercial Officer Late-breaker Abstract on Updated Phase 2 Results of IMMU-132 in Patients with mTNBC...
StoneCastle Financial Corp. Reports Third Quarter 2017 Results
Nov 09, 2017 21:10 pm UTC| Business
NEW YORK, Nov. 09, 2017 -- StoneCastle Financial Corp. (Nasdaq:BANX) (“StoneCastle Financial” or the “Company”), an investment company registered with the Securities and Exchange Commission (“SEC”), today announced...
Tervita Corporation Announces Q3 2017 Financial Results Conference Call
Nov 09, 2017 21:06 pm UTC| Business
CALGARY, Alberta, Nov. 09, 2017 -- Tervita Corporation announced today it will hold a conference call to discuss its Q3 2017 financial results. The call will be held on Friday, November 17, 2017 at 2:00 p.m....
Zosano Pharma Reports Third Quarter 2017 Financial Results and Operational Update
Nov 09, 2017 21:06 pm UTC| Business
First patient enrolled in long term safety study in November 2017Phase 2/3 data presented at International Headache Society in SeptemberClinical results published in two leading scientific journalsAccess to capital...
Identiv Reports Third Quarter 2017 Financial Results
Nov 09, 2017 21:06 pm UTC| Business
FREMONT, Calif., Nov. 09, 2017 -- Identiv, Inc. (NASDAQ:INVE), a global provider of physical security and secure identification, reported results for the third quarter ended September 30, 2017. Third Quarter 2017...
Chiasma Reports Third Quarter 2017 Results
Nov 09, 2017 21:06 pm UTC| Business
WALTHAM, Mass., Nov. 09, 2017 -- Chiasma, Inc. (NASDAQ:CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today reported financial...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update